| Product Code: ETC5360141 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The corticosteroids market in Sweden is influenced by the rising prevalence of chronic inflammatory diseases and allergies. These medications are widely used in the treatment of conditions such as asthma, rheumatoid arthritis, and psoriasis. As awareness of these conditions grows, the demand for corticosteroids is expected to increase. The market is characterized by a mix of generic and branded products, with several pharmaceutical companies investing in research and development to introduce novel formulations and delivery methods. Additionally, regulatory frameworks governing drug approvals and pricing strategies play a crucial role in shaping market dynamics.
The corticosteroids market in Sweden is primarily driven by the rising prevalence of chronic inflammatory diseases such as asthma, arthritis, and dermatological conditions. The increasing awareness of these diseases and the availability of advanced corticosteroid therapies are significantly boosting market demand. Additionally, the growth in the elderly population, who are more susceptible to chronic conditions, further drives the need for corticosteroids. The ongoing research and development activities focused on creating novel corticosteroid formulations with fewer side effects also contribute to market growth. Moreover, the increasing healthcare expenditure and better access to healthcare facilities enhance the adoption of corticosteroid treatments among patients.
In the corticosteroids market in Sweden, one of the key challenges is the increasing scrutiny over the long-term side effects of corticosteroid use. Patients and healthcare providers are becoming more cautious about the risks of prolonged usage, including osteoporosis, diabetes, and immune suppression. Furthermore, stringent regulatory requirements for drug approval and manufacturing processes increase the cost and complexity for pharmaceutical companies. Another challenge is the rise of alternative therapies, such as biologics, which are often preferred for treating chronic conditions due to their more targeted action and fewer side effects.
In Sweden, the regulation of corticosteroids falls under the Swedish Medical Products Agency, which ensures that these drugs meet stringent safety and efficacy standards. Government policies emphasize the controlled use of corticosteroids to prevent misuse and over-prescription, particularly in treating chronic conditions. Reimbursement policies under the public healthcare system facilitate access to these medications, although prescription guidelines ensure responsible use to avoid potential side effects. Regulatory approvals and compliance with the European Medicines Agency (EMA) standards are also crucial for market participants.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Corticosteroids Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Corticosteroids Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Corticosteroids Market - Industry Life Cycle |
3.4 Sweden Corticosteroids Market - Porter's Five Forces |
3.5 Sweden Corticosteroids Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Sweden Corticosteroids Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden Corticosteroids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of inflammatory diseases and allergies in Sweden |
4.2.2 Growing awareness about the benefits of corticosteroids in managing various health conditions |
4.2.3 Rising geriatric population in Sweden leading to higher demand for corticosteroids |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and marketing of corticosteroid products in Sweden |
4.3.2 Competition from alternative treatment options such as non-steroidal anti-inflammatory drugs (NSAIDs) |
5 Sweden Corticosteroids Market Trends |
6 Sweden Corticosteroids Market Segmentations |
6.1 Sweden Corticosteroids Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Sweden Corticosteroids Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.1.3 Sweden Corticosteroids Market Revenues & Volume, By Rhuematology Indications, 2021-2031F |
6.1.4 Sweden Corticosteroids Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.1.5 Sweden Corticosteroids Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.1.6 Sweden Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
6.2 Sweden Corticosteroids Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Sweden Corticosteroids Market Revenues & Volume, By Hospitals, 2021-2031F |
6.2.3 Sweden Corticosteroids Market Revenues & Volume, By Clinics, 2021-2031F |
6.2.4 Sweden Corticosteroids Market Revenues & Volume, By Research Institutes, 2021-2031F |
6.2.5 Sweden Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
7 Sweden Corticosteroids Market Import-Export Trade Statistics |
7.1 Sweden Corticosteroids Market Export to Major Countries |
7.2 Sweden Corticosteroids Market Imports from Major Countries |
8 Sweden Corticosteroids Market Key Performance Indicators |
8.1 Prescription rates of corticosteroids by healthcare providers in Sweden |
8.2 Patient adherence to corticosteroid treatment regimens |
8.3 Number of clinical trials and research studies conducted on corticosteroids in Sweden |
9 Sweden Corticosteroids Market - Opportunity Assessment |
9.1 Sweden Corticosteroids Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Sweden Corticosteroids Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden Corticosteroids Market - Competitive Landscape |
10.1 Sweden Corticosteroids Market Revenue Share, By Companies, 2024 |
10.2 Sweden Corticosteroids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here